Role of PD-1 during effector CD8 T cell differentiation

Area of Science:

• Immunology
• Virology
• Cellular Biology

Background:

• Programmed cell death-1 (PD-1) is a key inhibitory receptor on T cells, primarily known for regulating T cell exhaustion in chronic infections and cancer.
• The role of PD-1 during acute viral infections, particularly in early T cell differentiation, remains incompletely understood.

Purpose of the Study:

• To investigate the expression kinetics and functional role of PD-1 in CD8 T cells during acute lymphocytic choriomeningitis virus (LCMV) infection.
• To determine if modulating the PD-1 pathway early in acute infection impacts T cell effector function and viral clearance.

Main Methods:

• Monitoring PD-1 expression on virus-specific CD8 T cells following LCMV infection in mice.
• Utilizing antigen receptor signaling stimulation and blockade of the PD-1 pathway with antibodies (anti-PD-L1, anti-PD-1).
• Assessing downstream signaling pathways (mTOR) and effector molecule expression (granzyme B) in CD8 T cells.

Main Results:

• PD-1 expression rapidly increased on naive CD8 T cells within 24 hours of LCMV infection, driven by antigen receptor signaling.
• Early blockade of PD-1 signaling enhanced mTOR signaling and granzyme B expression in CD8 T cells.
• PD-1 blockade led to accelerated clearance of the LCMV infection.

Conclusions:

• PD-1 exerts an inhibitory effect on the transition of naive CD8 T cells to effector cells during acute viral infections.
• The PD-1 pathway is amenable to modulation during the early stages of T cell differentiation.
• Targeting PD-1 in combination with vaccination strategies may offer a novel therapeutic approach for viral infections.